IP Verse

Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring - EP2545939

The patent EP2545939 was granted to Biomarin Pharmaceutical on Dec 16, 2020. The application was originally filed on Apr 11, 2008 under application number EP12005352A. The patent is currently recorded with a legal status of "Revoked".

EP2545939

BIOMARIN PHARMACEUTICAL
Application Number
EP12005352A
Filing Date
Apr 11, 2008
Status
Revoked
Jul 7, 2023
Grant Date
Dec 16, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CORIPHARMA EHFSep 16, 2021ARNASON FAKTORADMISSIBLE
BETAPHARM ARZNEIMITTELSep 15, 2021HAMM & WITTKOPPADMISSIBLE
STADA ARZNEIMITTELSep 14, 2021HAMM & WITTKOPPADMISSIBLE
TEVA PHARMACEUTICALSSep 14, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBWITHDRAWN
DIPHARMAJul 13, 2021ELKINGTON AND FIFEWITHDRAWN

Patent Citations (57) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONCA2420374
DESCRIPTIONEP0079574
DESCRIPTIONEP0191335
DESCRIPTIONEP1757293
DESCRIPTIONJPH0482888
DESCRIPTIONJPH09157270
DESCRIPTIONJPS5921685
DESCRIPTIONUS2002076782
DESCRIPTIONUS2002106645
DESCRIPTIONUS2002187958
DESCRIPTIONUS2003032616
DESCRIPTIONUS2006040946
DESCRIPTIONUS2601215
DESCRIPTIONUS3505329
DESCRIPTIONUS4540783
DESCRIPTIONUS4550109
DESCRIPTIONUS4587340
DESCRIPTIONUS4595752
DESCRIPTIONUS4649197
DESCRIPTIONUS4665182
DESCRIPTIONUS4701455
DESCRIPTIONUS4713454
DESCRIPTIONUS4752573
DESCRIPTIONUS4758571
DESCRIPTIONUS4774244
DESCRIPTIONUS4920122
DESCRIPTIONUS4937342
DESCRIPTIONUS5037981
DESCRIPTIONUS5198547
DESCRIPTIONUS5350851
DESCRIPTIONUS5401844
DESCRIPTIONUS5698408
DESCRIPTIONUS5753656
DESCRIPTIONUS5874433
DESCRIPTIONUS5922713
DESCRIPTIONUS5945452
DESCRIPTIONUS6011040
DESCRIPTIONUS6274581
DESCRIPTIONUS6410535
DESCRIPTIONUS6441038
DESCRIPTIONUS6544994
DESCRIPTIONWO2005049000
DESCRIPTIONWO2005049614
DESCRIPTIONWO2006055511
EXAMINATIONWO2005049000
OPPOSITIONEP1708690
OPPOSITIONEP2139485
OPPOSITIONUS2006211701
OPPOSITIONUS4550109
OPPOSITIONWO2005049000
OPPOSITIONWO2006034373
OPPOSITIONWO2006055511
OPPOSITIONWO2008128049
OTHEREP1708690
OTHEREP2139485
OTHERWO2005049000
SEARCHUS4550109

Non-Patent Literature (NPL) Citations (61) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BASAK ET AL., INDIAN J. PHARM. SCI., (2004), vol. 66, page 827-
DESCRIPTION- CAI ET AL., CARDIOVASCULAR RESEARCH, (2002), vol. 55, pages 838 - 849-
DESCRIPTION- CHATTARAJ ET AL., DRUG DEVETOP. IND. PHARM., (1996), vol. 22, page 555-
DESCRIPTION- CHRISTENSEN ET AL., GENE THERAPY, (2000), vol. 7, pages 1971 - 1978-
DESCRIPTION- CHRISTENSEN ET AL., MOL. GENT. AND METABOL., (2002), vol. 76, pages 313 - 318-
DESCRIPTION- COLOMBO, ADV. DRUG DELIV- REV., (1993), vol. 11, page 37-
DESCRIPTION- DAVIS ET AL., EUR. J. BIOCHEM., (1988), vol. 173, pages 345 - 351-
DESCRIPTION- DAVIS, EUR. J. BIOCHEM., (1988), vol. 173, pages 345 - 351-
DESCRIPTION- "Disorders of tetrahydrobiopterin and related biogenic amines", BLAU ET AL., The Metabolic and Molecular Bases of Inherited Disease. 8th ed., MCGRAW-HILL, (2001), pages 1275 - 1776-
DESCRIPTION- FIEGE ET AL., MOLECULAR GENETICS AND METABOLISM, (2004), vol. 81, pages 45 - 51-
DESCRIPTION- FUKUSHIMA; NIXON, ANAL BIOCHEM., (1980), vol. 102, pages 176 - 188-
DESCRIPTION- FULDSHIMA ET AL., ANAL. BIOCHEM., (1980), vol. 102, page 176-
DESCRIPTION- KIRSCH ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 24481 - 24490-
DESCRIPTION- LEE ET AL., DRUG DEVELOP. LND- PHARM., (1999), vol. 25, page 493-
DESCRIPTION- MATSUNRA ET AL., CHEM. LETT.-
DESCRIPTION- MATSUURA ET AL., CHEM. LETT., (1984), page 735-
DESCRIPTION- MATSUURA ET AL., HETEROCYCLES, (1985), vol. 23, no. 12, pages 3115 - 3120-
DESCRIPTION- NAROHASHI ET AL., PHARM RES, (2003), vol. 19, pages 1415 - 1421-
DESCRIPTION- NOZAWA ET AL., J. PHARM SCI., (2003), vol. 92, no. 11, pages 2208 - 2216-
DESCRIPTION- PABON ET AL., DRUG DEVELOP. IND. PHARM., (1992), vol. 18, page 2163-
DESCRIPTION- PAL LIU, ARTS. CELLS. BLOOD SUBS AND IMMOB. BIOTECH., (2002), vol. 30, no. 4, pages 243 - 257-
DESCRIPTION- RAJABI-SIABHOOMI ET AL., J. PH?RM. PHARMACOL., (1992), vol. 44, page 1062-
DESCRIPTION- Remington's Pharmaceutical Sciences, 18th Ed., MACK PUBL. CO, (1990), pages 1435 - 1712-
DESCRIPTION- SCHIRCKS ET AL., HELV. CHIM. ACTA, (1977), vol. 60, page 211-
DESCRIPTION- SUGIMOTO ET AL., BULL CHEM SOC. JP, (1975), vol. 48, no. 12, page 3767-
DESCRIPTION- SUGIMOTO ET AL., BULL. CHEM SOC. JP, (1979), vol. 52, no. 1, page 181-
DESCRIPTION- SUGIMOTO; MATSUURA, BULL CHEM SOC. JAPAN, (1975), vol. 48, no. 12, pages 3767 - 3768-
DESCRIPTION- SUGIMOTO; MATSUURA, BULL CHEM. SOC- JAPAN, (1979), vol. 52, no. 1, pages 181 - 183-
DESCRIPTION- VISONTINI ET AL., HELV. CHIM ACTA, (1969), vol. 52, page 1225-
DESCRIPTION- WHITELEY ET AL., ANAL BIOCHEM., (1984), vol. 137, no. 2, pages 394 - 6-
OPPOSITION- Anonymous, "Kuvan facts 1", The National Society for Phenylketonuria (UK) Ltd, (20170101), pages 1 - 2, The National Society for Phenylketonuria (UK) Ltd, URL: http://www.nspku.org/sites/default/files/publications/NSPKU_A4_Kuvan_Longform_1.pdf, (20180205), XP055447859-
OPPOSITION- Anonymous, "Paediatric investigation plan Decision", EMA P/0232/2013, (20130923), pages 1 - 10, EMA P/0232/2013, (20180205), XP055447873-
OPPOSITION- Anonymous, "What you should know about PKU", BioMarin information leaflet, (20060101), XP055933461-
OPPOSITION- Asiem, Et Al, "The PKU Handbook", HGSA, (20050101), HGSA, URL: https://www.hgsa.org.au/documents/item/48, (20180208), XP055449418-
OPPOSITION- FDA, "Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies", Guidance for industry, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, US, US , (20021201), pages 1 - 12, XP008138108-
OPPOSITION- Heyman Sydney, " Gastric Emptying in Children", THE JOURNALOFNUCLEARMEDICIN, (19980501), vol. 39, no. 5, pages 865 - 869, XP055933437-
OPPOSITION- H. O. De Baulny, Et Al, "Management of phenylketonuria and hyperphenylalaninemia", The Journal of Nutrition, American Society for Nutrition, US, US , (20070101), vol. 137, no. 6 Suppl 1, ISSN 0022-3166, pages 1579s - 1585s, XP055447882-
OPPOSITION- Leggett R, "ANNEX C: REVIEW OF TRANSIT TIMES THROUGH MAJOR SEGMENTS OF THE ALIMENTARY TRACT", ICRP, (20060101), pages 203 - 232, ICRP, (20220621), XP055933428-
OPPOSITION- Mclachlan Andrew, Et Al, "Meals and medicines", Aust Prescr, (20060101), pages 40 - 42, Aust Prescr, URL: https://www.nps.org.au/assets/47171dee404e1be5-e9be7f6e0cf2-f63c4030b61d1139331706218a82a9ed1e2b5fa8bce5df07bc9a064b3b3f.pdf, (20210923), XP055844120-
OPPOSITION- M. R. Zurflüh ; L. Fiori ; B. Fiege ; I. Ozen ; M. Demirkol ; K. H. Gärtner ; B. Thöny ; M. Giovannini ; N. Blau, "Pharmacokinetics of orally administered tetrahydrobiopterin in patients with phenylalanine hydroxylase deficiency", Journal of Inherited Metabolic Disease, Kluwer Academic Publishers, Do, Do , (20061107), vol. 29, no. 6, doi:10.1007/s10545-006-0425-6, ISSN 1573-2665, pages 725 - 731, XP019447470
OPPOSITION- Perez-Duenas, B. Vilaseca, M.A. Mas, A. Lambruschini, N. Artuch, R. Gomez, L. Pineda, J. Gutierrez, A. Mila, M. Campistol, J., "Tetrahydrobiopterin responsiveness in patients with phenylketonuria", Clinical Biochemistry, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20041201), vol. 37, no. 12, doi:10.1016/j.clinbiochem.2004.09.005, ISSN 0009-9120, pages 1083 - 1090, XP004674795
OPPOSITION- B Fiege, "Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration", Molecular Genetics and Metabolism, Academic Press, AMSTERDAM, NL, AMSTERDAM, NL , (20040101), vol. 81, no. 1, doi:10.1016/j.ymgme.2003.09.014, ISSN 1096-7192, pages 45 - 51, XP055405456
OPPOSITION- Nenad Blau, Heidi Erlandsen, "The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency", Molecular Genetics and Metabolism, Academic Press, AMSTERDAM, NL, AMSTERDAM, NL , (20040601), vol. 82, no. 2, doi:10.1016/j.ymgme.2004.03.006, ISSN 1096-7192, pages 101 - 111, XP055449408
OPPOSITION- BERNEGGER C, BLAU N, "HIGH FREQEUNCY OF TETRAHYDROBIOPTERIN-RESPONSIVENESS AMONG HYPERPHENYLALANINEMIAS:A STUDY OF 1919 PATIENTS OBSERVED FROM 1988 TO 2002", Molecular Genetics and Metabolism, Academic Press, AMSTERDAM, NL, AMSTERDAM, NL , (20020101), vol. 77, no. 04, doi:10.1016/S1096-7192(02)00171-3, ISSN 1096-7192, pages 304 - 313, XP008064071
OPPOSITION- A. C. MUNTAU et al., "Tetrahydrobiopterin as an Alternative Treatment for Mild Phenylketonuria", N Engl J Med, (20020000), vol. 347, no. 26, doi:10.1056/NEJMoa021654, pages 2122 - 2132, XP055189023
OPPOSITION- MUNTAU A C, ET AL., "TETRAHYDROBIOPTERIN AS AN ALTERNATIVE TREATMENT FOR MILD PHENYLKETONURIA", New England Journal of Medicine, The - NEJM, Massachusetts Medical Society, US, US , (20021226), vol. 347, no. 26, doi:10.1056/NEJMoa021654, ISSN 1533-4406, pages 2122 - 2132, XP008064072
OPPOSITION- Stegink L D, Filer L J, Brummel M C, Baker G L, Krause W L, Bell E F, Ziegler E E, "Plasma amino acid concentrations and amino acid ratios in normal adults and adults heterozygous for phenylketonuria ingesting a hamburger and milk shake meal", American Journal of Clinical Nutrition, (19910301), vol. 53, no. 3, doi:10.1093/ajcn/53.3.670, ISSN 0002-9165, pages 670 - 675, XP055933420
OPPOSITION- Iris Scala ET AL, "Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience", Orphanet Journal of Rare Diseases, BioMed Central Ltd, Lo, Lo , (20150208), vol. 10, no. 1, doi:10.1186/s13023-015-0227-8, ISSN 1750-1172, pages 1 - 12, XP021214439
OPPOSITION- Alberto Ponzone, Et Al, "Tetrahydrobiopterin Loading Test in Hyperphenylalaninemia", Pediatric Research, Lippincott Williams & Wilkins, New York, US, US , (19911101), vol. 30, no. 5, doi:10.1203/00006450-199111000-00008, ISSN 0031-3998, pages 435 - 438, XP055449404
OPPOSITION- Deniz Kör, Et Al, "Improved metabolic control in tetrahydrobiopterin (BH4), responsive phenylketonuria with sapropterin administered in two divided doses vs. a single daily dose", JOURNAL OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM., Walter de Gruyter GmbH, DE, DE , (20170101), vol. 30, no. 7, doi:10.1515/jpem-2016-0461, ISSN 0334-018X, pages 713 - 718, XP055447870
OPPOSITION- Donohoe K. J., Maurer A. H., Ziessman H. A., Urbain J.-L. C., Royal H. D., Martin-Comin J., "Procedure Guideline for Adult Solid-Meal Gastric-Emptying Study 3.0", JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY., SOCIETY OF NUCLEAR MEDICINE, NEW YORK, NY., US, US , (20090901), vol. 37, no. 3, doi:10.2967/jnmt.109.067843, ISSN 0091-4916, pages 196 - 200, XP055933440
OTHER- ASIEM et al, "The PKU Handbook", HGSA, ( ), page 1-2,46, URL: https://www.hgsa.org.au/documents/item/48, XP055449418-
OTHER- "Food-Effect Bioavailability and Fed Bioequivalence Studies", Guidance for Industry-FDA, (20021200), XP008138108-
OTHER- "Kuvan facts", The National Society for Phenylketonuria (UK) Ltd, (20170000), pages 1 - 2, URL: http://www.nspku.org/sites/default/files/publications/NSPKU_A4_Kuvan_Longform_1.pdf, XP055447859-
OTHER- OGIER DE BAULNY H. et al., "Management of phenylketonuria and hyperphenylalaninemia", J. Nutr., (20070000), vol. 117, no. 6 Suppl 1, pages 1561S - 1563S, XP055447882-
OTHER- "Paediatric investigation plan Decision", EMA P/0232/2013, (20130923), pages 1 - 10, XP055447873-
OTHER- BLAU N. et al., "The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency", Molecular Genetics and Metabolism, (20040600), vol. 82, no. 2, pages 101 - 111, XP055449408
OTHER- BERNEGGER C. et al., "High frequency of tetrahydrobiopterin-responsiveness amonghyperphenylalaninemias: a study of 1919 patients observed from1988 to 2002", Molecular Genetics and Metabolism, (20020000), vol. 77, no. 4, pages 304 - 313, XP008064071
OTHER- SCALA I. et al., "Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years expenence", Orphanet Journal of Rare Disease, (20150000), vol. 10, no. 1, pages 1 - 12, XP021214439
OTHER- PONZONE A. et al., "Tetrahydrobiopterin Loading Test in Hyperphenylalaninemia", Pediatr. Res., (19911100), vol. 30, no. 5, pages 435 - 438, XP055449404
OTHER- KOR D. et al., "Improved metabolic control in tetrahydrobiopterin (BH4), responsive phenylketonuria with sapropterin administered in two divided doses vs. a single daily dose", J. Pediatr. Endocrinol. Metab., (20170000), vol. 30, no. 7, pages 713 - 718, XP055447870

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents